Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
multiple sclerosis subtype
|
| gptkbp:affects |
central nervous system
|
| gptkbp:alsoKnownAs |
gptkb:RRMS
|
| gptkbp:autoimmuneDisease |
true
|
| gptkbp:canProgressTo |
gptkb:secondary_progressive_MS
|
| gptkbp:cause |
demyelination
nerve damage |
| gptkbp:characterizedBy |
episodes of neurological symptoms
periods of remission |
| gptkbp:diagnosedBy |
neurological examination
MRI lumbar puncture |
| gptkbp:firstDescribed |
19th century
|
| gptkbp:gender |
more common in women
|
| https://www.w3.org/2000/01/rdf-schema#label |
relapsing-remitting MS
|
| gptkbp:mostCommonFormOf |
multiple sclerosis
|
| gptkbp:onset |
20-40 years
|
| gptkbp:prevalence |
most common MS type (about 85% at diagnosis)
|
| gptkbp:riskFactor |
smoking
genetic predisposition vitamin D deficiency environmental factors |
| gptkbp:subspecies |
multiple sclerosis
|
| gptkbp:symptom |
fatigue
muscle weakness difficulty with coordination numbness vision problems |
| gptkbp:treatment |
disease-modifying therapies
physical therapy corticosteroids |
| gptkbp:bfsParent |
gptkb:Multiple_Sclerosis
|
| gptkbp:bfsLayer |
5
|